The platform functions as an extension of Dragon Copilot, which already automates the documentation of patient visits. By analyzing the conversation alongside a patient's medical history, current medications, payer rules, and social context, RhythmX Pulse generates immediate, evidence-based recommendations. These suggestions cover coding opportunities, care-gap alerts, and medication alternatives, which clinicians can review, edit, or dismiss before a patient leaves the exam room.

Deepthi Bathina, CEO and founder of GW RhythmX, emphasized that the technology moves beyond basic summarization to provide hyper-personalized clinical intelligence. For health systems already utilizing Dragon Copilot, the integration requires no separate implementation process. This launch marks the initial stage of a broader collaboration between the two companies, with plans to expand AI-driven support into pre-visit preparation and long-term patient management. To date, the platform has undergone more than 170,000 physician-reviewed clinical validations to ensure accuracy and safety in its automated recommendations.